Company · CIK 1563880
Trevi Therapeutics, Inc.
| CIK | 1563880 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CT |
| Listed | TRVI (Nasdaq) |
| First annual or quarterly report | 2019-06-14 |
Offerings
9 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-291517 | 2025-11-13 | 2026-04-17 | 3 | |
| 333-273030 | 2023-06-29 | 2025-06-04 | 5 | |
| 333-239499 | 2020-06-26 | 2022-09-23 | 5 | |
| 333-264614 | 2022-05-02 | 2022-05-11 | 2 | |
| 333-260820 | 2021-11-05 | 2021-11-16 | 2 | |
| 333-260279 | 2021-10-15 | 2021-10-25 | 2 | |
| 333-259120 | 2021-08-27 | 2021-10-08 | 2 | |
| 333-257747 | 2021-07-07 | 2021-07-14 | 2 | |
| 333-230745 | 2019-04-05 | 2019-05-08 | 6 |
Filings
30| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-04-17 | 424B5Shelf takedown | 333-291517 | 0001193125-26-161582 |
| 2026-04-16 | 424B5Shelf takedown | 333-291517 | 0001193125-26-159041 |
| 2025-11-13 | S-3ASRShelf registered | 333-291517 | 0001193125-25-280501 |
| 2025-06-04 | 424B5Shelf takedown | 333-273030 | 0001193125-25-134905 |
| 2025-06-02 | 424B5Shelf takedown | 333-273030 | 0001193125-25-133344 |
| 2024-12-16 | 424B5Shelf takedown | 333-273030 | 0001193125-24-279709 |
| 2023-08-15 | EFFECTDeclared effective | 333-273030 | 9999999995-23-002394 |
| 2023-06-29 | S-3Shelf registered | 333-273030 | 0001193125-23-178727 |
| 2022-09-23 | 424B5Shelf takedown | 333-239499 | 0001193125-22-250276 |
| 2022-09-22 | 424B5Shelf takedown | 333-239499 | 0001193125-22-249167 |
| 2022-05-16 | 424B5Shelf takedown | 333-239499 | 0001564590-22-020201 |
| 2022-05-11 | EFFECTDeclared effective | 333-264614 | 9999999995-22-001421 |
| 2022-05-02 | S-3Shelf registered | 333-264614 | 0001564590-22-017057 |
| 2021-11-16 | EFFECTDeclared effective | 333-260820 | 9999999995-21-004369 |
| 2021-11-05 | S-3Shelf registered | 333-260820 | 0001193125-21-321577 |
| 2021-10-25 | EFFECTDeclared effective | 333-260279 | 9999999995-21-004024 |
| 2021-10-15 | S-3Shelf registered | 333-260279 | 0001193125-21-300007 |
| 2021-10-08 | RWWithdrawn | 333-259120 | 0001193125-21-295518 |
| 2021-08-27 | S-1Registration filed | 333-259120 | 0001193125-21-259333 |
| 2021-07-14 | EFFECTDeclared effective | 333-257747 | 9999999995-21-002767 |
| 2021-07-07 | S-1Registration filed | 333-257747 | 0001193125-21-209928 |
| 2020-07-02 | EFFECTDeclared effective | 333-239499 | 9999999995-20-001643 |
| 2020-06-26 | S-3Shelf registered | 333-239499 | 0001193125-20-181094 |
| 2019-05-08 | 424B4Final prospectus | 333-230745 | 0001193125-19-141374 |
| 2019-05-07 | EFFECTDeclared effective | 333-230745 | 9999999995-19-001033 |
| 2019-05-07 | S-1/AAmendment | 333-230745 | 0001193125-19-138831 |
| 2019-05-06 | S-1/AAmendment | 333-230745 | 0001193125-19-138079 |
| 2019-04-22 | S-1/AAmendment | 333-230745 | 0001193125-19-112820 |
| 2019-04-05 | S-1Registration filed | 333-230745 | 0001193125-19-099340 |
| 2018-11-19 | DRSDraft made public | 377-02377 | 0000950123-18-012153 |